EDGAR Filing Documents for 0000950133-05-000116

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0000950133-05-000116

Filing Date

2005-01-13

Accepted

2005-01-13 08:00:24

Documents

Period of Report

2004-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	w04074e20vf.htm	20-F	1094869
2	EXHIBIT 4.1	w04074exv4w1.htm	EX-4.1	105160
3	EXHIBIT 4.2	w04074exv4w2.htm	EX-4.2	103698
4	EXHIBIT 4.3	w04074exv4w3.htm	EX-4.3	104944
5	EXHIBIT 4.5	w04074exv4w5.htm	EX-4.5	99902
6	EXHIBIT 4.6	w04074exv4w6.htm	EX-4.6	102861
7	EXHIBIT 4.7	w04074exv4w7.htm	EX-4.7	110800
8	EXHIBIT 4.8	w04074exv4w8.htm	EX-4.8	107818
9	EXHIBIT 8.1	w04074exv8w1.htm	EX-8.1	6579
10	EXHIBIT 12.1	w04074exv12w1.htm	EX-12.1	13994
11	EXHIBIT 13.1	w04074exv13w1.htm	EX-13.1	3942
	Complete submission text file	0000950133-05-000116.txt		1857199

Mailing Address 107 NORTH RYDE SYDNEY C3 1670

Business Address 140 WICKS RD NORTH RYDE NEW SOUTH WALES 2113 C3 2113 01161298780088

NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-29962 | Film No.: 05527058
SIC: 2834 Pharmaceutical Preparations